Research portfolio
The CCTR supports a growing portfolio of pediatric clinical studies across multiple disease areas. Below are studies currently enrolling participants and those in the startup phase.
Currently Enrolling Studies
These studies are actively enrolling participants. For questions about eligibility or participation, contact the CCTR team.
TRIUMPH Study of immunosuppressive therapy for children with acute liver failure.
| EMERALD-2 Safety and PK/PD of patiromer in children with hyperkalemia
| MATIC-2 Massive Transfusion Protocol in Children Following Trauma Sponsor: BARDA |
HIKO STEC Hyperhydration in children with hemolytic uremic syndrome Sponsor: NIH/PECARN | PPHNet Bold Evaluation of efficacy of combination medical therapy (vs. monotherapy) for pulmonary hypertension
| EMPA-Kids Phase 3 study of empagliflozin in 2–17-year-olds with chronic kidney disease |
Xylitol COG Use of xylitol wipes to prevent bloodstream infections in patients with AML
|
Studies in Startup
Coming soon
These studies have been initiated and are progressing through regulatory approval, contracting, or protocol finalization prior to opening enrollment.
ABOUT TIME Evaluation of educational approaches to improve blood pressure in children with lupus Sponsor: PCORI |
Interested in collaborating or referring a patient?
Contact our team to learn more about any of our active studies or to discuss research partnership opportunities.
CONTACT THE CCTR